Remarkably, our results revealed that combinatorial REST targeting using GR-28 and the fatty acid pathway inhibitor Triacsin C led to synergistic cell death in glioblastoma cells with high basal REST levels (Fig. 6G). The gene discussed is REST; the disease is glioblastoma.